Jackson ImmunoResearch Laboratories
Jackson ImmunoResearch Laboratories is a privately held, ISO 9001:2015-certified manufacturer founded in 1982 in West Grove, Pennsylvania, producing over 3,880 secondary antibodies and conjugates (whole IgG, F(ab')2, Fab, VHH nanobodies, ImmunoGold) for academic, pharmaceutical, and in vitro diagnostics researchers worldwide via direct e-commerce and distributor channels.
- Company typePrivate
- Founded1982
- HeadquartersWest Grove, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Jackson ImmunoResearch Laboratories does
Jackson ImmunoResearch Laboratories (legal entity Jackson ImmunoResearch Inc.) is a privately held specialty manufacturer founded in 1982 and headquartered at 872 West Baltimore Pike, West Grove, Pennsylvania. The company designs, develops, and manufactures secondary antibodies and conjugates for immunological research applications, holding ISO 9001:2015 certification (FM 545248). Its catalog comprises over 3,880 secondary antibody products organized into whole IgG (2,029 SKUs), F(ab')2 fragment (800 SKUs), Fab fragment (120 SKUs), FabuLight Fc-specific fragments (154 SKUs), anti-mouse IgG subclass-specific reagents (104 SKUs), fluorescent protein conjugates including R-PE/APC/PerCP (121 SKUs), Brilliant Violet (130 SKUs), Near-InfraRed (102 SKUs), Cyanine (72 SKUs), and ImmunoGold colloidal gold conjugates (73 SKUs) in sizes from 4 nm to 40 nm. The company also markets a proprietary AffiniPure-VHH line of alpaca-derived nanobody secondary antibodies and a 699-SKU Antibodies for Diagnostics category serving in vitro diagnostics manufacturers with anti-human reagents and 40 nm ImmunoGold for lateral flow immunoassays.
The company's underlying technology rests on affinity purification, cross-adsorption for species specificity, and diverse conjugate chemistries spanning enzymatic (HRP, alkaline phosphatase), fluorescent (Alexa Fluor, Cyanine, Brilliant Violet, NIR, R-PE/APC/PerCP), and colloidal gold reporters. The proprietary AffiniPure-VHH platform leverages alpaca VHH fragment antibodies for enhanced tissue penetration and reduced steric hindrance in high-resolution immunostaining. Multiple labeling (ML) antibodies with cross-reactivity removed enable multiplex immunofluorescence without species cross-reactivity artifacts, and lot-to-lot consistency is a documented manufacturing priority for reproducible immunoassay workflows across Western blot, ELISA, flow cytometry, immunofluorescence, immunohistochemistry, and electron microscopy applications.
Jackson ImmunoResearch generates revenue through transactional, unit-priced sales of consumable antibody reagents. Pricing ranges from approximately $78-$94 for unconjugated whole IgG antibodies, $142-$179 for fluorescent conjugates, $171-$191 for enzyme conjugates, and $150-$333 for high-precision specialty and ML antibodies, with bulk ordering available for larger volumes. Distribution is direct-to-customer via the jacksonimmuno.com e-commerce storefront and a 1-800 phone line, supplemented by a wholly-owned European subsidiary (JIR Europe), Cambridge Bioscience as the dedicated UK distributor, and a broader international distributor network. Customer segments include academic and independent research institutions, pharmaceutical and biotechnology companies (with Janssen Research & Development cited as a named enterprise customer), and in vitro diagnostics manufacturers. The company is recognized by Verified Market Research as one of five key players in the global secondary antibodies market alongside Thermo Fisher Scientific, BD Biosciences, Santa Cruz Biotechnology, and Bio-Rad.
Jackson ImmunoResearch Laboratories firmographics
Firmographics- Name
- Jackson ImmunoResearch Laboratories
- Legal name
- Jackson ImmunoResearch Inc.
- Website
- https://jacksonimmuno.com
- Company type
- Private
- Founded year
- 1982
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Jackson ImmunoResearch Laboratories is a privately held, ISO 9001:2015-certified manufacturer founded in 1982 in West Grove, Pennsylvania, producing over 3,880 secondary antibodies and conjugates (whole IgG, F(ab')2, Fab, VHH nanobodies, ImmunoGold) for academic, pharmaceutical, and in vitro diagnostics researchers worldwide via direct e-commerce and distributor channels.
- Ownership category
- akta.pro rank
Jackson ImmunoResearch Laboratories industry classification
Industry- Product category
- Life Science Research Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Jackson ImmunoResearch Laboratories is headquartered
LocationHeadquarters
- HQ city
- West Grove
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Jackson ImmunoResearch Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Secondary Antibody and Conjugate Sales: Jackson ImmunoResearch generates revenue primarily through the sale of secondary antibodies, primary antibodies, streptavidin conjugates, and blocking reagents. Products are sold in various formats (whole IgG, F(ab')2 fragments, Fab fragments) and conjugate options (enzymatic, fluorescent, colloidal gold). Revenue is transactional with one-time purchases, though repeat customer relationships are common due to the consumable nature of antibodies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard Whole IgG Antibodies - Unconjugated |
| Unit Pricing | Pay-as-you-go | Fluorescent Protein Conjugates |
| Unit Pricing | Pay-as-you-go | Enzyme Conjugates |
| Unit Pricing | Pay-as-you-go | High-Precision Specialty Antibodies |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Jackson ImmunoResearch Laboratories product offering
Product offeringCore offering
Jackson ImmunoResearch Laboratories manufactures secondary antibodies, primary antibodies, and antibody-enzyme/fluorophore conjugates in formats such as whole IgG, F(ab')2 fragments, and Fab fragments, used in immunoassay applications including western blotting, ELISA, immunofluorescence, immunohistochemistry, and flow cytometry. The company also produces alpaca-derived VHH (nanobody) secondary antibodies under its AffiniPure-VHH line and supplies bulk diagnostic-grade antibodies to in-vitro diagnostic (IVD) manufacturers.
Product overview
Jackson ImmunoResearch Laboratories specializes in secondary antibodies and conjugates for immunoassay research and diagnostics. The product portfolio centers on over 3,880 secondary antibody products organized into major categories: Secondary Antibodies (the core offering including Whole IgG, F(ab')₂ Fragment, and Fab Fragment formats), AffiniPure-VHH® Secondary Antibodies (VHH/nanobody technology for high-resolution imaging), Antibodies for Diagnostics (capture reagents including anti-human antibodies and ImmunoGold for LFIA), Primary Antibodies (anti-tag and anti-reporter), Streptavidin and Conjugates, Blocking and Controls (serums, BSA, and purified proteins), and Antisera. Products are offered across multiple conjugate types including fluorescent proteins (R-PE, APC, PerCP), Brilliant Violet™, Near-InfraRed dyes, Cyanine dyes, enzymes (HRP, AP), biotin, and ImmunoGold particles in various sizes. The company holds ISO 9001:2015 certification and serves academic institutions, pharmaceutical companies, and biotechnology firms for applications in Western blotting, ELISA, flow cytometry, immunofluorescence, and electron microscopy.
Differentiator
Problem solved
Functional benefit
Brands
- AffiniPure-VHH®: Polyclonal VHH fragment secondary antibodies for high-resolution immunostaining
- FabuLight™
- ChromPure®
Products and services
- Secondary Antibodies
Quantifiable outcome
- Long-term chip/plate reusability: anti-human reagents can be reused for weeks to a month without losing capturing capacity or surface integrity
- +1 more outcomes
Companies that use Jackson ImmunoResearch Laboratories
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Jackson ImmunoResearch Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Jackson ImmunoResearch Laboratories partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Cambridge BiosciencecoreCambridge Bioscience serves as the exclusive UK distributor for Jackson ImmunoResearch products. UK customers are directed to place orders directly through Cambridge Bioscience rather than through the US website. This partnership ensures regulatory compliance and localized support for UK research institutions.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Jackson ImmunoResearch Laboratories competitors and assessment
Company assessmentDirect peers
- LI-COR Biosciences: Specialty reagent and instrument company with IRDye-conjugated secondary antibodies widely used in Western blot and imaging applications. Competes with JIR in fluorescent secondary antibody SKUs, particularly for near-infrared imaging workflows.
- Santa Cruz Biotechnology: Specialty antibody manufacturer offering a broad catalog of primary and secondary antibodies for research applications. Directly comparable to JIR in product type, customer base (academic and pharma researchers), and distribution model.
- Rockland Immunochemicals: Specialty antibody and reagent manufacturer with a comparable catalog of secondary antibodies and custom antibody services. Closely analogous mid-sized specialty player with strong presence in Western blot and immunoassay reagents.
- Abcam: Leading research antibody supplier offering primary and secondary antibodies, with deep catalog and recombinant antibody technology. Directly comparable in target customer (academic/biopharma researchers) and overlapping secondary antibody SKUs.
- Cell Signaling Technology: Specialty antibody company focused on signal transduction and immune-related targets, supplying both primary and secondary antibodies with strong brand authority among academic and pharma researchers. Competes directly with JIR for the same reagent budget at the same customer accounts.
Broad incumbents
- Bio-Rad Laboratories: Established life science tools and clinical diagnostics company whose secondary antibody offering (e.g., Bio-Rad Antibodies, formerly AbD Serotec) competes head-to-head with JIR's catalog. Cited alongside JIR as a key player in the secondary antibodies market.
- BD Biosciences: Major life sciences and clinical diagnostics supplier cited as a key player in the secondary antibodies market. Overlaps with JIR in flow cytometry secondary antibodies and broader reagent portfolio for immunology research.
- Sigma-Aldrich (MilliporeSigma): Global life science chemicals and reagents supplier whose secondary antibody portfolio (under the Sigma and Roche brands) competes across the same academic and biopharma customers. Operates a broad catalog and benefits from bundling with chemicals and consumables.
- Thermo Fisher Scientific: Global life sciences tools leader offering secondary antibodies (e.g., Invitrogen) alongside primary antibodies, instruments, and full immunoassay workflows. Competes with JIR in secondary antibody procurement but operates a far broader catalog and serves as a one-stop platform supplier.
Emerging players
- Proteintech: Specialty antibody manufacturer that has rapidly scaled a catalog of primary and secondary antibodies with strong academic and pharma adoption. Comparable in product category and customer base, and represents the type of catalog-deep competitor that pressures incumbent specialists.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Jackson ImmunoResearch Laboratories social profiles
Digital presenceJackson ImmunoResearch Laboratories compliance and trust
Trust signalCompliance1 record
Jackson ImmunoResearch Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jackson ImmunoResearch Laboratories leadership team
Management profileNumber of profiles
Jackson ImmunoResearch Laboratories subsidiaries and ownership
Company hierarchySubsidiaries1 record
Jackson ImmunoResearch Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jackson ImmunoResearch Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jackson ImmunoResearch Laboratories
What does Jackson ImmunoResearch Laboratories do?
Jackson ImmunoResearch Laboratories manufactures secondary antibodies, primary antibodies, and antibody-enzyme/fluorophore conjugates in formats such as whole IgG, F(ab')2 fragments, and Fab fragments, used in immunoassay applications including western blotting, ELISA, immunofluorescence, immunohistochemistry, and flow cytometry. The company also produces alpaca-derived VHH (nanobody) secondary antibodies under its AffiniPure-VHH line and supplies bulk diagnostic-grade antibodies to in-vitro diagnostic (IVD) manufacturers.
Is Jackson ImmunoResearch Laboratories a public or private company?
Jackson ImmunoResearch Laboratories is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Jackson ImmunoResearch Laboratories founded?
Jackson ImmunoResearch Laboratories was founded in 1982. It employs 51 to 100 people.
Where is Jackson ImmunoResearch Laboratories based?
Jackson ImmunoResearch Laboratories is headquartered in West Grove, United States, in the North America region.
How does Jackson ImmunoResearch Laboratories make money?
One revenue line is on record: secondary Antibody and Conjugate Sales.
Who are Jackson ImmunoResearch Laboratories's main competitors?
Direct peers on record are LI-COR Biosciences, Santa Cruz Biotechnology, Rockland Immunochemicals, Abcam and Cell Signaling Technology. Broad incumbents are Bio-Rad Laboratories, BD Biosciences, Sigma-Aldrich (MilliporeSigma) and Thermo Fisher Scientific. Proteintech is listed as an emerging player.
Does Jackson ImmunoResearch Laboratories have an API?
No public API is recorded for Jackson ImmunoResearch Laboratories.
What industry is Jackson ImmunoResearch Laboratories in?
Jackson ImmunoResearch Laboratories's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument). Its NAICS code is 325413 and its SIC code is 2835.